Authors
Latest:
Observations from AACR 2014This year the AACR conference was focused on "Harnessing Breakthroughs, Targeting Cures."
Latest:
Personalized HealthcareWhat works when and for whom in the era of comparative effectiveness research.
Latest:
Sustaining InnovationConstant technological advancements continue to alter the compliance battle.
Latest:
Risk-Based ApproachesThe eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.
Latest:
Objective Internal MonitoringSponsors are responsible for monitoring studies, patient safety, and data integrity.
Latest:
State of the industry: Data & Technology in Clinical TrialsTeaming up with Eli Lilly and DrugDev Advisory Board, eyeforpharma conducted a 'State of the Industry' survey to investigate how pharma is currently leveraging data and technology and how this will change over the next 2 years. Highlights include: - Adopt a risk based approach for a cheaper way to clean your data, ensure optimum data quality and patient safety - Integrate real world and real time data for faster data generation, to quickly demonstrate value to patients and find urgent answers to unmet needs - Overcome rising R&D costs by utilizing big data to identify patient sub groups, integrate patients into research stages to better identify new biomarkers and provide more personalized treatments - See how mobile and wearable devices encourage patient participation by virtualizing parts of trials, reduce patient burden and enhance data quality
Latest:
Strengthening the Links in the Clinical Supply Chain: Aim for Transparency throughout the ProcessMost business leaders acknowledge the pitfalls of organizational silos: they breed inefficiency and signal systemic malfunctioning.
Latest:
Implementation and Usage of Data Monitoring CommitteesExploring sourcing model options for appropriate incorporation of DMCs into a clinical program.
Latest:
Are Phase III Clinical Trials Really Consistently Behind Schedule?With a unique business model, pharmaceutical companies and their subcontractors need to find every way possible to shorten drug development times consistent with patient safety. The challenges facing commercially oriented organizations developing prescription drugs are substantial.
Latest:
Achieve Sustained Clinical Trials Quality in a Functional Service ProvisionFunctional service provisions can provide sponsors and CROs with a way to efficiently manage clinical trial outsourcing methods.
Latest:
Personalized HealthcareWhat works when and for whom in the era of comparative effectiveness research.
Latest:
Personalized HealthcareWhat works when and for whom in the era of comparative effectiveness research.
Latest:
How to Improve Clinical Research in Children: A Survey on the Perception of European Pediatricians and Industry/CROsThe Pediatric Working Group of the European CRO Federation conducted a follow-up survey on the status of pediatric clinical trials in Europe.
Latest:
The Shifting Paradigm in Clinical Trial Design for Anti-cancer DrugsHow molecular profiling is impacting today's cancer medicine.
Latest:
Risk-Based ApproachesThe eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.
Latest:
Patient-Reported Outcomes in Oncology: If No One Pays Attention to Data, Does it Really Exist?In a recent piece published in the New England Journal of Medicine, oncologist Dr. Ethan Basch talks about his perspective that patient-reported outcomes (PROs) are not widely used in the development process for cancer drugs because they are not often measured in clinical trials.
Latest:
Patient-First Approach to Improve Oncology Clinical TrialsLife can change in an instant, but there is one thing that always abides: hope.
Latest:
Risk-Based ApproachesThe eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.
Latest:
Outsourcing: China Takes Center StageConversion from paper to ePRO for an instrument designed to assess diabetes' impact on quality of life.
Latest:
Warning Letter StudyAn analysis of warning letters and the findings reported from 1996 to 2010.
Latest:
Regulatory Considerations Surrounding Human Challenge Studies with the SARS-CoV-2 VirusA first vaccine against this coronavirus could still take some time to develop, but mRNA vaccine platforms could offer an early breakthrough.
Latest:
Optimizing Trial Supplies Via Integrated e-PlatformseGSP-driven approach focuses on overcoming operational challenges through data integration.
Latest:
eSource Records in Clinical Research: Keeping it SimpleHow to satisfy regulatory concerns about EDC data integrity and site controls over its source records.
Latest:
Optimizing Trial Supplies Via Integrated e-PlatformseGSP-driven approach focuses on overcoming operational challenges through data integration.
Latest:
Risk Assessment and MitigationA quantitative approach to enhancing risk assessment and mitigation in drug development.
